Literature DB >> 11590838

The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channels.

E D Michelakis1, E K Weir.   

Abstract

Chronic hypoxic pulmonary arterial hypertension, APAH, and PPAH are characterized by vasoconstriction and vascular remodeling and are associated with decreased Kv currents in PA smooth muscle cells. Although Kv2.1 is less well studied, it seems that Kv1.5 is particularly important in the pulmonary circulation in animals and humans because it has been implicated in physiologic phenomena (HPV) and all of the aforementioned pulmonary hypertensive disorders. This occurrence is perhaps because of the fact that it controls Em in the PA smooth muscle cells and it has a short turnover half time. It is also certain that the pathogenesis of PPAH is multifactorial and not a result of a single abnormality. The recently discovered "PPAH gene" in chromosome 2q in patients with familial PPAH (6%-12% of patients) does not seem to encode for any Kv channels. Kv1.5 abnormalities, however, are likely to be a strong predisposing factor that, in association with others such as endothelial dysfunction, [figure: see text] anorexigen use, or viral infections, will initiate a process that eventually leads to PPAH. The selective Kv1.5 down-regulation leaves wide open the door to replacement gene therapy in pulmonary hypertension research.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590838     DOI: 10.1016/s0272-5231(05)70281-1

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  6 in total

Review 1.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

2.  Reactive oxygen species scavengers improve voltage-gated K(+) channel function in pulmonary arteries of newborn pigs with progressive hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; Judy L Aschner; Mark R Kaplowitz; Yongmei Zhang; Jane A Madden
Journal:  Pulm Circ       Date:  2013-11-20       Impact factor: 3.017

Review 3.  Ion channel trafficking: a new therapeutic horizon for atrial fibrillation.

Authors:  Sarah M Schumacher; Jeffrey R Martens
Journal:  Heart Rhythm       Date:  2010-02-13       Impact factor: 6.343

4.  Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension.

Authors:  Sébastien Bonnet; Eric Dumas-de-La-Roque; Hugues Bégueret; Roger Marthan; Michael Fayon; Pierre Dos Santos; Jean-Pierre Savineau; Etienne-Emile Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

Review 5.  The role of the NO axis and its therapeutic implications in pulmonary arterial hypertension.

Authors:  Evangelos D Michelakis
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

6.  Expression of KCNA5 Protein in Human Mammary Epithelial Cell Line Associated with Caveolin-1.

Authors:  Jia Liu; Chao Qu; Hongyan Li; Yejun Zhang; Jia Sun; Shuo Yang; Jing Liu; Lijia An; Wei Zou
Journal:  J Membr Biol       Date:  2016-04-13       Impact factor: 1.843

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.